Nucor (NUE) Stock Forecast & Price Target

Q: What analysts cover Nucor?

Nucor has been rated by research analysts at Barclays , BMO Capital Markets , Citigroup , Freedom Broker , JPMorgan Chase & Co. , KeyCorp , Morgan Stanley , The Goldman Sachs Group , UBS Group , Weiss Ratings , and Wells Fargo & Company in the past 90 days.

$246.01 -0.43 (-0.18%)

Closing price 10/8/2026 03:59 PM Eastern

Extended Trading

$248.45 +2.45 (+0.99%)

As of 08:31 AM Eastern

Compare

Nucor - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 17 Analyst Ratings

Sell
0

Hold
4

Buy
13

Based on 17 Wall Street analysts who have issued ratings for Nucor in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 17 analysts, 4 have given a hold rating, and 13 have given a buy rating for NUE.

Consensus Price Target

$276.93
12.57% Upside

According to the 17 analysts' twelve-month price targets for Nucor, the average price target is $276.93. The highest price target for NUE is $308.00, while the lowest price target for NUE is $248.00. The average price target represents a forecasted upside of 12.57% from the current price of $246.01.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for NUE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Nucor and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NUE Analyst Ratings Over Time

Type	Current Forecast 10/9/25 to 10/9/26	1 Month Ago 9/9/25 to 9/9/26	3 Months Ago 7/11/25 to 7/11/26	1 Year Ago 10/9/24 to 10/9/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	13 Buy rating(s)	13 Buy rating(s)	11 Buy rating(s)	8 Buy rating(s)
Hold	4 Hold rating(s)	3 Hold rating(s)	4 Hold rating(s)	2 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$276.93	$274.38	$266.15	$156.60
Forecasted Upside	12.57% Upside	6.35% Upside	17.10% Upside	13.49% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

NUE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

NUE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Nucor Stock vs. The Competition

Type	Nucor	Materials Companies	Broader Market
Consensus Rating Score	2.76	2.57	2.52
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	12.57% Upside	155.04% Upside	19.62% Upside
News Sentiment Rating	Neutral News See Recent NUE News	Neutral News	Neutral News

Recent Analyst Forecasts and Stock Ratings

Show

Rating

Upside/Downside

Action

Report Date

0 Results

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
10/5/2026	KeyCorp 2 of 5 stars	Samuel McKinney Not Rated	Lower Target	Overweight	$288.00 ➝ $286.00	+19.01%
9/18/2026	Wells Fargo & Company 3 of 5 stars	Timna Tanners 4 of 5 stars	Lower Target	Overweight	$285.00 ➝ $280.00	+5.44%
9/18/2026	The Goldman Sachs Group 3 of 5 stars		Lower Target	Buy	$304.00 ➝ $302.00	+22.30%
9/18/2026	Freedom Broker Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vitaly Kononov Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Hold	$305.00 ➝ $285.00	+14.28%
9/9/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bennett Moore Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$294.00 ➝ $308.00	+19.46%
8/25/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold (C+) ➝ Buy (B-)
7/29/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Katja Jancic Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$285.00 ➝ $295.00	+11.88%
7/29/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexander Hacking Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy
7/29/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Garchitorena Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$272.00 ➝ $295.00	+11.11%
7/29/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Carlos De Alba Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$270.00	+1.69%
Get the Latest News and Ratings for NUE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Nucor and its competitors with MarketBeat's FREE daily newsletter.
7/28/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Jones Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$224.00 ➝ $256.00	-3.30%
7/9/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lawson Winder Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$290.00 ➝ $280.00	+23.44%
6/29/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
5/25/2026	CICC Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Outperform
5/15/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$200.00 ➝ $262.00	+14.47%
5/4/2026	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Outperform	$210.00 ➝ $248.00	+8.71%
4/28/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$225.00 ➝ $250.00	+12.11%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 08:23 AM ET.

Should I Buy Nucor Stock? NUE Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, October 5, 2026. Please send any questions or comments about these Nucor pros and cons to contact@marketbeat.com.

Nucor
Bull Case

Here are some ways that investors could benefit from investing in Nucor Co.:

The stock is currently trading at $251.51, which is significantly below the consensus price target of $276.07 set by seventeen research firms, suggesting a potential upside of approximately 10% for investors who believe the current valuation is too low.
Nucor Co. recently reported second-quarter earnings of $4.84 per share, beating the consensus estimate of $4.46 by $0.38, while revenue of $10.40 billion also exceeded analyst expectations, demonstrating strong operational performance and profitability with a net margin of 7.99%.
The company has received a "Moderate Buy" consensus rating from analysts, with thirteen firms issuing Buy ratings and only four issuing Hold ratings, indicating broad institutional confidence in the stock's future performance.
Nucor Co. maintains a strong balance sheet with a debt-to-equity ratio of 0.27 and a current ratio of 2.51, which provides financial stability and the ability to weather economic downturns or invest in growth opportunities without excessive leverage.
The stock has shown strong momentum, climbing 5% in a single session to add $2.9 billion in market value, and is trading well above its 200-day moving average of $232.25, signaling positive technical trends and investor interest.

Nucor
Bear Case

Investors should be bearish about investing in Nucor Co. for these reasons:

The company's third-quarter 2026 earnings guidance of $5.55 to $5.65 per share missed market expectations of $6.17, leading to a drop in the stock price as investors digest the softer-than-expected outlook for the upcoming quarter.
Insider selling has been significant, with 26 sales and zero purchases in the past six months, including large transactions by executives like Leon J. Topalian and David A. Sumoski, which may signal a lack of confidence from those closest to the company's operations.
The stock has a high beta of 1.84, meaning it is significantly more volatile than the overall market, which could lead to larger price swings and higher risk for investors who are sensitive to market fluctuations.
Short interest has increased slightly to 4,291,283 shares, representing 1.9% of the float, indicating that some investors are betting against the stock's performance, which could create downward pressure on the price.
The company's raw materials segment is expected to weaken in the third quarter, and the second-quarter results benefited from non-recurring gains such as a $61 million non-cash gain from its Helion investment and $130 million in procurement refunds, which may not be sustainable in future periods.

NUE Forecast - Frequently Asked Questions

According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Nucor is $276.93, with a high forecast of $308.00 and a low forecast of $248.00.

17 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nucor in the last year. There are currently 4 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" NUE shares.

According to analysts, Nucor's stock has a predicted upside of 12.57% based on their 12-month stock forecasts.

Over the previous 90 days, Nucor's stock had 1 upgrade and 1 downgrade by analysts.

Nucor has been rated by research analysts at Barclays, BMO Capital Markets, Citigroup, Freedom Broker, JPMorgan Chase & Co., KeyCorp, Morgan Stanley, The Goldman Sachs Group, UBS Group, Weiss Ratings, and Wells Fargo & Company in the past 90 days.

Analysts like Nucor more than other "materials" companies. The consensus rating score for Nucor is 2.76 while the average consensus rating score for "materials" companies is 2.57. Learn more on how NUE compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Nucor Recommendations

MarketBeat monitors more than a dozen sources for Nucor analyst ratings, with the most recent rating issued on 10/5/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nucor (NUE) Stock Forecast & Price Target